Gilead Sciences Inc (GILD)
65.27
-1.81
(-2.70%)
USD |
NASDAQ |
Apr 25, 16:00
65.15
-0.12
(-0.18%)
After-Hours: 20:00
Gilead Sciences Price to Book Value: 3.561 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 3.561 |
| April 24, 2024 | 3.660 |
| April 23, 2024 | 3.657 |
| April 22, 2024 | 3.653 |
| April 19, 2024 | 3.642 |
| April 18, 2024 | 3.610 |
| April 17, 2024 | 3.652 |
| April 16, 2024 | 3.672 |
| April 15, 2024 | 3.696 |
| April 12, 2024 | 3.714 |
| April 11, 2024 | 3.746 |
| April 10, 2024 | 3.717 |
| April 09, 2024 | 3.816 |
| April 08, 2024 | 3.788 |
| April 05, 2024 | 3.796 |
| April 04, 2024 | 3.795 |
| April 03, 2024 | 3.868 |
| April 02, 2024 | 3.933 |
| April 01, 2024 | 3.976 |
| March 28, 2024 | 3.996 |
| March 27, 2024 | 3.983 |
| March 26, 2024 | 3.951 |
| March 25, 2024 | 3.96 |
| March 22, 2024 | 3.962 |
| March 21, 2024 | 3.988 |
| Date | Value |
|---|---|
| March 20, 2024 | 4.036 |
| March 19, 2024 | 4.005 |
| March 18, 2024 | 3.997 |
| March 15, 2024 | 4.020 |
| March 14, 2024 | 4.049 |
| March 13, 2024 | 4.143 |
| March 12, 2024 | 4.096 |
| March 11, 2024 | 4.110 |
| March 08, 2024 | 4.099 |
| March 07, 2024 | 4.019 |
| March 06, 2024 | 3.963 |
| March 05, 2024 | 3.982 |
| March 04, 2024 | 3.942 |
| March 01, 2024 | 3.945 |
| February 29, 2024 | 3.934 |
| February 28, 2024 | 3.966 |
| February 27, 2024 | 3.984 |
| February 26, 2024 | 3.980 |
| February 23, 2024 | 4.013 |
| February 22, 2024 | 3.971 |
| February 21, 2024 | 3.994 |
| February 20, 2024 | 3.930 |
| February 16, 2024 | 3.905 |
| February 15, 2024 | 4.004 |
| February 14, 2024 | 3.986 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.446
Minimum
Mar 10 2022
5.431
Maximum
Jul 20 2020
4.260
Average
4.277
Median
Jan 12 2021
Price to Book Value Benchmarks
| Amgen Inc | 23.17 |
| Johnson & Johnson | 5.144 |
| Eli Lilly and Co | 63.98 |
| Pfizer Inc | 1.602 |
| CymaBay Therapeutics Inc (DELISTED) | 12.76 |
Price to Book Value Related Metrics
| PE Ratio | 14.50 |
| PS Ratio | 3.028 |
| PEG Ratio | 0.6228 |
| Price to Free Cash Flow | 11.06 |
| Price | 65.27 |
| Earnings Yield | 6.89% |
| Market Cap | 81.31B |
| PEGY Ratio | 0.5196 |
| Operating PE Ratio | 9.321 |
| Normalized PE Ratio | 12.43 |